Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,994 public trials 1,520 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy

NCT03352934

Conditions
Adenocarcinoma, Cancer, Carcinoma, +8 more
Locations
  • Poliklinik für Innere Medizin I Universitätsklinikum Halle Halle, Germany
  • Nationales Centrum für Tumorerkrankungen Universitätsklinikum Heidelberg Heidelberg, Germany
  • Schwerpunkt Endokrinologie und Stoffwechselerkrankungen Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany
  • Klinik für Innere Medizin, Abteilung Gastroenterologie Universitätsklinikum Gießen und Marburg Marburg, Germany
View Trial Details
Completed

Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor

NCT03985072

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Carcinoma, +38 more
Locations
  • Fundacion Arturo Lopez Perez Santiago, Santiago Metropolitan, Chile
  • Centro de Cancer de Nuestra Senora de la Esperanza, Red de Salud UC CHRISTUS Santiago, Santiago Metropolitan, Chile
  • Instituto Nacional del Cáncer (INCANCER) Santiago, Santiago Metropolitan, Chile
  • Centro de Investigaciones Clinicas Vina del Mar Viña del Mar, V Region de Valparaiso, Chile
View Trial Details
Completed

Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer

NCT03794544

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Fort Myers, Florida, United States
  • Research Site Leesburg, Florida, United States
  • Research Site Baltimore, Maryland, United States
View all 18 locations
View Trial Details
Completed

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

NCT01328626

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 52902 Tucson, Arizona, United States
  • Ucsd /Id# 48325 La Jolla, California, United States
  • Dana-Farber Cancer Institute /ID# 48324 Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center /ID# 56810 New York, United States
View Trial Details
Completed

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

NCT00101972

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +80 more
Locations
  • Premiere Oncology Santa Monica, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

NCT02493751

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Scottsdale Healthcare Hospitals d/b/a HonorHealth Scottsdale, Arizona, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Completed

A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components

NCT02549222

Conditions
Acute Lung Injury, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
View all 15 locations
View Trial Details

Related conditions